Royal Bank of Canada
AYLA

Royal Bank of Canada’s Ayala Pharmaceuticals, Inc. Common Stock AYLA Stock Holding History

Royal Bank of Canada’s Portfolio AYLA Stock Details AYLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-1,250
Closed -$14K – 7817
2021
Q1 		$14K Buy
+1,250
New +$17.8K ﹤0.01% 6656
2020
Q4 		– Sell
-459
Closed -$5K – 7399
2020
Q3 		$5K Buy
+459
New +$5.37K ﹤0.01% 6153

Other funds holding AYLA

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
MWNA
Marshall Wace North America New York $23.5B AUM 46.46% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Royal Bank of Canada's AYLA Position: Q2 2021 in Review

Royal Bank of Canada sold out of Ayala Pharmaceuticals, Inc. Common Stock (AYLA) in Q2 2021, closing a stake of 1,250 shares — an estimated $14K sold.

Royal Bank of Canada first reported a position in AYLA in Q3 2020 and held it in 2 quarters. The position peaked at $14K in Q1 2021. 12 funds tracked by Wall St. Rank hold AYLA as of Q2 2021.

  • Royal Bank of Canada reported no remaining Ayala Pharmaceuticals, Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
  • Royal Bank of Canada sold 1,250 Ayala Pharmaceuticals, Inc. Common Stock shares in Q2 2021, an estimated $14K.
  • Royal Bank of Canada first reported a position in Ayala Pharmaceuticals, Inc. Common Stock in Q3 2020 and held it in 2 quarters.
  • Royal Bank of Canada's Ayala Pharmaceuticals, Inc. Common Stock position peaked at $14K in Q1 2021.
  • 12 funds tracked by Wall St. Rank held Ayala Pharmaceuticals, Inc. Common Stock as of Q2 2021.

Based on Royal Bank of Canada's 13F filing for Q2 2021, filed 16 Aug 2021.